Haemonetics - M&A Summary and Business Overview

Medical ProductsCompany

Haemonetics M&A Summary

Haemonetics has acquired 15 companies, including 4 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.

Haemonetics’ largest acquisition to date was in 2012, when it acquired Pall - Transfusion Medicine Business for $551M. Haemonetics has acquired in 7 different US states, and 3 countries. The Company’s most targeted sectors include medical products (54%) and software (27%).

Haemonetics Business Overview

Where is Haemonetics headquartered?

Haemonetics is headquartered in Boston, Massachusetts.

What is Haemonetics’ revenue?

Haemonetics disclosed revenue of 1,309M USD for 2024 and 1,169M USD for 2023.

How many employees does Haemonetics have?

Haemonetics has 2,708 employees.

What sector is Haemonetics in?

Haemonetics is a medical products company.

When was Haemonetics founded?

Haemonetics was founded in 1971.

M&A Summary

  • M&A Total Activity17
    • M&A Buy Activity15
    • M&A Sell Activity2
  • Total Sectors Invested 4
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 4
  • M&A Advisors 3

Haemonetics

Haemonetics Corp.

125 Summer Street,
Boston, Massachusetts 02110
United States,
(781) 848-7100
www.haemonetics.com

Haemonetics is a healthcare company dedicated to providing innovative blood management solutions for customers. The company devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients worldwide. Haemonetics was founded in 1971 and is based in Boston, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.8/yr) # 11 1 1 - 1 1 15
vol $731M $475M $253M $1.5B
Sell (0.2/yr) # 1 1 - - - - 2
  17

Most Recent M&A

Company Date Value Type
Advanced Cooling Therapy, Inc. 2024-03-05 - Add-on Acquisition
Chicago, Illinois · www.attune-medical.com
OpSens, Inc. 2023-10-10 253M USD Add-on Acquisition
Quebec City, Quebec · www.opsens.com
Cardiva Medical, Inc. 2021-01-20 475M USD Add-on Acquisition
Sunnyvale, California · www.cardivamedical.com
Inlog Holdings France SAS 2020-07-24 - Divestiture
Limonest, France
enicor GmbH 2020-04-02 - Add-on Acquisition
Munich, Germany · www.clot.pro
Haemonetics Corp. - SEBRA 2017-04-27 - Divestiture
Braintree, Massachusetts
Hemerus Medical LLC 2013-05-01 27M USD Add-on Acquisition
St. Paul, Minnesota · www.hemerus.com
Pall - Transfusion Medicine Business 2012-08-01 551M USD Divestiture
, United States
Global Med Technologies, Inc. 2010-02-01 60M USD Add-on Acquisition
El Dorado Hills, California · www.globalmedtech.com
Engineering and Research Associates, Inc.(aka SEBRA) 2009-09-08 13M USD Add-on Acquisition
Tucson, Arizona · www.sebra.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 8 (53%) 1.4B (93%) 1 (50%) -
Software 4 (27%) 70M (5%) 1 (50%) -
Life Science 2 (13%) 13M (1%) - -
Test/Measurement Equipment 1 (7%) 26M (2%) - -
Total 15 $1.5B 2 -

By Geo

State/Country Buy Value Sell Value
United States 12 1.2B 1 -
  Illinois 4 79M - -
  California 3 535M - -
  Massachusetts 1 - 1 -
  Pennsylvania 1 1M - -
  Minnesota 1 27M - -
  Arizona 1 13M - -
Canada 2 253M - -
  Quebec 1 253M - -
  British Columbia 1 - - -
France - - 1 -
Germany 1 - - -
Domestic 12 (80%) 1.2B (83%) 1 (50%) -
Cross-border 3 (20%) 253M (17%) 1 (50%) -
Total 15 $1.5B 2 -

Top M&A Advisors

Financial Deals
Moelis & Co.
1
Goldman Sachs
1
Legal Deals
DLA Piper
3

Deal Values

buy # Total
$100M to $1B 3 $1.3B
< $100M 7 $180M
TOTAL $1.5B
Largest Pall - Transfusion Medicine Business
$551M (2012-08-01)

M&A Connections

Deals
Acquired from
Investor(s)
7%
1 (7%)
Strategic(s)
7%
1 (7%)
Divested to
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.